Sernova's Disruptive Regenerative Medicine Technologies Set to...

London, Ontario-based Sernova Corp., is developing a better way to treat the disease involving the replacement of lost pancreatic islets, whose function is to read blood sugar levels and release insulin into the blood, normalizing blood sugar levels.

http://ift.tt/1b55Bsc